Highnoon Laboratories (KAR:HINOON) Beginning Cash Position: ₨549 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:HINOON Highnoon Laboratories Ltd KAR:HINOON
96 GF Score
Price ₨910.96
GF Value ₨1,028.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Highnoon Laboratories Beginning Cash Position?

Highnoon Laboratories KAR:HINOON -0.31% 96 Beginning Cash Position is ₨549 Mil as of Jun. 2026. GuruFocus rates KAR:HINOON with a GF Score™ of 96/100 and a GF Value™ of ₨1,028.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Highnoon Laboratories's Beginning Cash Position for the quarter that ended in Jun. 2026 was ₨549 Mil.

Highnoon Laboratories's quarterly Beginning Cash Position declined from Dec. 2025 (₨802 Mil) to Mar. 2026 (₨282 Mil) but then increased from Mar. 2026 (₨282 Mil) to Jun. 2026 (₨549 Mil).

Highnoon Laboratories's annual Beginning Cash Position increased from Dec. 2023 (₨-224 Mil) to Dec. 2024 (₨-48 Mil) and increased from Dec. 2024 (₨-48 Mil) to Dec. 2025 (₨710 Mil).

Highnoon Laboratories Beginning Cash Position Related Terms

Highnoon Laboratories Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Highnoon Laboratories's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Highnoon Laboratories Beginning Cash Position Chart

Highnoon Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 863.13 770.44 -224.40 -47.82 709.52

Highnoon Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 681.79 1,132.65 801.51 282.43 548.67
KAR:HINOON
96GF Score
Highnoon Laboratories Ltd KAR:HINOON
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Highnoon Laboratories Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ₨549 Mil mean?
Highnoon Laboratories (KAR:HINOON) has a Beginning Cash Position of ₨549 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Highnoon Laboratories and its competitors.
Is Highnoon Laboratories' Beginning Cash Position too high?
Highnoon Laboratories' current Beginning Cash Position is ₨549 Mil. Overall, Highnoon Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Highnoon Laboratories' Beginning Cash Position compare to LLY and JNJ?
Highnoon Laboratories' Beginning Cash Position of ₨549 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Highnoon Laboratories and its competitors. Highnoon Laboratories's current Beginning Cash Position is ₨549 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Highnoon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Highnoon Laboratories (KAR:HINOON) is currently considered Modestly Undervalued. The stock's GF Value™ is ₨1,028.55, compared to a current price of ₨910.96 — trading 11.4% below its estimated fair value. The current Beginning Cash Position is ₨549 Mil. Highnoon Laboratories' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Highnoon Laboratories (KAR:HINOON), the current Beginning Cash Position is ₨549 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Highnoon Laboratories (KAR:HINOON) Overvalued in 2026?

Based on GuruFocus' analysis, Highnoon Laboratories stock appears to be undervalued. The current stock price of ₨910.96 is trading 11.4% below its estimated GF Value™ of ₨1,028.55. GuruFocus considers Highnoon Laboratories to be Modestly Undervalued.

Key valuation signals for KAR:HINOON:

  • Beginning Cash Position: ₨549 Mil
  • GF Value™: ₨1,028.55 vs. price of ₨910.96 (11.4% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the KAR:HINOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Highnoon Laboratories Business Description

Address Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.
96GF Score

Get the complete analysis for KAR:HINOON

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨910.96
Price
₨1,028.55
GF Value